Norinchukin Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-693
| Closed | -$240K | – | 543 |
|
|
2024
Q1 | $240K | Sell |
693
-7
| -1% | -$2.42K | 0.01% | 530 |
|
|
2023
Q4 | $226K | Sell |
700
-25
| -3% | -$8.07K | 0.01% | 537 |
|
|
2023
Q3 | $260K | Sell |
725
-249
| -26% | -$89.3K | 0.01% | 521 |
|
|
2023
Q2 | $369K | Sell |
974
-280
| -22% | -$106K | 0.01% | 520 |
|
|
2023
Q1 | $601K | Buy |
1,254
+43
| +4% | +$20.6K | 0.01% | 466 |
|
|
2022
Q4 | $509K | Sell |
1,211
-212
| -15% | -$89.1K | 0.01% | 475 |
|
|
2022
Q3 | $594K | Buy |
1,423
+116
| +9% | +$48.4K | 0.01% | 456 |
|
|
2022
Q2 | $647K | Sell |
1,307
-663
| -34% | -$328K | 0.01% | 447 |
|
|
2022
Q1 | $1.11M | Buy |
1,970
+150
| +8% | +$84.5K | 0.01% | 437 |
|
|
2021
Q4 | $1.38M | Sell |
1,820
-12
| -0.7% | -$9.07K | 0.02% | 388 |
|
|
2021
Q3 | $1.37M | Buy |
1,832
+48
| +3% | +$35.8K | 0.02% | 379 |
|
|
2021
Q2 | $1.15M | Sell |
1,784
-8
| -0.4% | -$5.15K | 0.02% | 401 |
|
|
2021
Q1 | $1.02M | Buy |
1,792
+28
| +2% | +$16K | 0.01% | 418 |
|
|
2020
Q4 | $1.03M | Sell |
1,764
-30
| -2% | -$17.5K | 0.01% | 385 |
|
|
2020
Q3 | $925K | Buy |
1,794
+24
| +1% | +$12.4K | 0.01% | 377 |
|
|
2020
Q2 | $799K | Buy |
+1,770
| New | +$799K | 0.01% | 384 |
|